Relationship between portal venous and hepatic arterial blood flows: spectrum of response.
The relationship between portal tributary blood flow (PBF) and hepatic arterial blood flow (HAF) was studied in awake, unrestrained rats with the radiolabeled microsphere technique. Six distinct patterns of response emerged. In group A (PBF+, HAF 0), ethanol, acetate, glucagon, prostacyclin, and a mixed diet increased PBF without a change in HAF; in group B (PBF+, HAF+), adenosine and histamine increased both PBF and HAF; in group C (PBF 0, HAF+), isoflurane and triiodothyronine did not change PBF but increased HAF; and in group D (PBF-, HAF+), halothane and vasopressin decreased PBF and increased HAF. Acute partial portal vein ligation decreased PBF (56%) and increased HAF (436%). Hypoxia (7.5% O2) decreased PBF (28%) and increased HAF (110%). In group E (PBF+, HAF-), acute hepatic artery ligation increased PBF (35%) and reduced HAF (74%), while in group F (PBF-, HAF-), thyroidectomy reduced PBF and HAF (36 and 47%, respectively). All blood flow responses were accompanied by the expected changes in both portal tributary and hepatic arterial vascular resistances. The data suggest that the portal and hepatic arterial vascular territories have regulatory mechanisms that allow for independent changes.
Kawasaki
T
T
Addiction Research Foundation, Toronto, Ontario, Canada.
Carmichael
F J
FJ
Saldivia
V
V
Roldan
L
L
Orrego
H
H
D000085:Acetates / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D011464:Epoprostenol / Q000494:pharmacology; D000431:Ethanol / Q000494:pharmacology; D005934:Glucagon / Q000494:pharmacology; D006499:Hepatic Artery / Q000502:physiology*; D008102:Liver Circulation / Q000187:drug effects; D008297:Male; D008863:Microspheres; D011169:Portal Vein / Q000502:physiology*; D051381:Rats; D011919:Rats, Inbred Strains; D012039:Regional Blood Flow / Q000187:drug effects; D014284:Triiodothyronine / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects; D014667:Vasopressins / Q000494:pharmacology
D000085:Acetates; D014284:Triiodothyronine; D014667:Vasopressins; D000431:Ethanol; D005934:Glucagon; D011464:Epoprostenol